9th Annual Biomarkers Congress
Drug Development In China: Strategies for launching Discovery and Development activities
Park Hyatt Philadelphia
200 South Broad Street
Philadelphia, PA
http://www.healthtech.com/2007/pcc/day1.asp
Keywords: Drug Development China, Discoveries, Pharmaceutical Strategy

Event Sponsors

Schedule of Presentations:

Monday, September 10, 2007
08:15:00 AM Coffee and Conference Registration
08:45:00 Organizer’s Welcoming Remarks Micah Lieberman
09:00:00 OPENING KEYNOTES (09:00 - 11:45) Steve Q. Yang, Whaijen Soo, Guoxin Zhu
09:00:00 OPENING KEYNOTES: China as a Key in Increasing Productivity of Western Companies (09:00 - 09:45) Whaijen Soo
09:45:00 OPENING KEYNOTES: Pharmaceutical R&D in China: Leveraging Collaboration & Managing Risk for Maximum Value (09:45 - 10:30) Guoxin Zhu
10:30:00 Networking Coffee Break (10:30 - 11:00)
11:00:00 OPENING KEYNOTES: R&D Strategic Sourcing in China: A Dynamic View (11:00 - 11:45) Steve Q. Yang
11:45:00 OPENING KEYNOTES: Interactive Panel Discussion #1 (11:45 - 12:30) Guoxin Zhu, Steve Q. Yang, Whaijen Soo
12:30:00 Regulatory Overview of Counterfeit Drugs in China (12:30 - 14:00) Matthew Levy, Chris Song
14:00:00 Accelerating Drug R&D by Taking Advantage of China Resources (14:00 - 14:30) Samantha Du
14:30:00 Opportunities and Challenges of Conducting Clinical Studies, Drug Development, and Business Development in China (14:30 - 15:00) Michael Chen
15:00:00 Networking Refreshment Break (15:00 - 15:45)
15:45:00 How to Create Win-Win Situations with Academic Centers in China and Taiwan (15:45 - 16:15) Michael N. Liebman
16:15:00 CASE STUDY: Conducting Translational Medicine & Biomarker Validation in China (16:15 - 16:45) Andrew Branca
16:45:00 Interactive Panel Discussion #2 (16:45 - 17:45) Rajiv Gulati, Ming Guo, Samantha Du, Michael N. Liebman
17:45:00 Networking Cocktail Reception and One-on-One Meetings (17:45 - 18:45)
18:45:00 Close of Day One
Tuesday, September 11, 2007
07:30:00 Breakfast Workshop or Morning Coffee (07:30-08:00)
08:00:00 Chairperson’s Remarks (08:00-08:15)
08:15:00 SPECIAL PRESENTATION: CASE STUDY: Building a New Model of Regulatory Agency Interaction in China (08:15-09:00) Zili Li
09:00:00 The Optimal Combination – Outsourcing and Subsidiary Approach for Pharmaceutical Sciences Tasks (09:00-09:45) Ming Guo
09:45:00 Networking Coffee Break (09:45-10:30)
10:30:00 Current State of In Vivo Tox and Path Contract Research in China (10:30-11:00) Suresh Poosala
11:00:00 CASE STUDY: Collaborating to Assess Options for Conducting Preclinical Safety Studies in China (11:00-11:30) Eric Meyers
11:30:00 Interactive Panel Discussion#3 (11:30-12:15) Guoxin Zhu, Zili Li, Edmund Tsuei, Balu Balasubramanian
12:15:00 Luncheon and Strategic Solutions Presentations (Sponsorships available) or Lunch on Your Own (12:15-13:45)
13:45:00 Address Regulatory Challenges to Conduct Global Clinical Trials in China (13:45-14:15) Hua Zheng
14:15:00 CASE STUDY: Place of China in Global Drug Development Strategy (14:15-14:45) Edmund Tsuei
14:45:00 Networking Refreshment Break (14:45-15:15)
15:15:00 Clinical Trials in China – Trends, Opportunities and Lessons (15:15-15:45) Mark Engel
15:45:00 Navigating the Regulatory Landscape in China (15:45-16:15) Yiyou Chen
16:15:00 Interactive Panel Discussion #4 (16:15-16:45) Hua Zheng, Zili Li, Mark Engel
16:45:00 Close of Executive Forum
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.